August 2016

A cannabis leaf. Photo: Jon Richfield via Wikimedia Commons. JNS.org – An Israeli pediatrician has launched a clinical trial to study the effects of medical cannabis on autistic children and adults, Haaretz reported. Dr. Adi Eran, head of the pediatric neurology department at Shaare Zedek Medical Center in Jerusalem, is obtaining permits from Israel’s Ministry of Health […]

by

Israeli Doctor to Use Medical Cannabis to Treat Autism in First-of-Its-Kind Study, Report   In view of evidence that cannabinoids can help improve the quality of life of autistic people, an Israeli pediatrician has launched a first of… read more at: http://jewishbusinessnews.com/2016/08/30/israeli-doctor-to-use-medical-cannabis-to-treat-autism-in-first-of-its-kind-study-report/

by

Alzheimer’s disease is a bastard without a cure. It’s the sixth leading cause of death in America per the Center for Disease Control, and according to the Alzheimer’s Association, 1 in 9 American adults over 65 has it. However, there may be a ray of hope ahead for sufferers and their families. According to observational […]

by

Image Source: Getty Images. Unlike most biopharma stocks, GW Pharmaceuticals (NASDAQ:GWPH), a British company developing marijuana-based medicines, has turned in a stellar 2016. Specifically, the company’s shares are now up by nearly 20% year to date and have simply crushed the performance of the iShares Nasdaq Biotechnology ETF: IBB data by YCharts. GW’s unusual strength […]

by

Cannabinoids accomplish what Western medicine can’t – again! While approximately 138,000 American kids suffer from Tourette syndrome (TS) – roughly 1 in every 162 adolescents under the age of 17 – a single case study on treatment resistant Tourette syndrome indicates that cannabinoids may provide a therapeutic option; offering a hopeful light at the end […]

by

Image Source: Getty Images. Unlike most biopharma stocks, GW Pharmaceuticals (NASDAQ:GWPH), a British company developing marijuana-based medicines, has turned in a stellar 2016. Specifically, the company’s shares are now up by nearly 20% year to date and have simply crushed the performance of the iShares Nasdaq Biotechnology ETF: IBB data by YCharts. GW’s unusual strength […]

by

SAN DIEGO, CA–(Marketwired – August 25, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The San Francisco Money Show’s Cannabis Investing Symposium, which the Company is sponsoring, Medical Marijuana, Inc. CEO Dr. Stuart Titus will speak to investors about current global […]

by

Positive results from two phase 1b studies of ALZ-801 (Alzheon Inc.) have provided the clinical data necessary to move ALZ-801 into a pivotal phase 3 program in patients with Alzheimer’s disease (AD) who are homozygous for the epsilon-4 allele of the apolipoprotein E gene (APOE4/4). ALZ-801 is an “optimized” prodrug of tramiprosate. In 2009, tramiprosate […]

by

As more and more states across the US push towards marijuana reform, investors are increasingly seeing the plant and its chemical compounds as an emerging industry; ripe for the taking in what is fast becoming a multi-billion dollar business . Over the years they’ve garnered a little action in the OTC market, but we’re taking a […]

by

By Dania Duran As more and more states across the US push towards marijuana reform, investors are increasingly seeing the plant and its chemical compounds as an emerging industry, ripe for the taking in what is fast becoming a multi-billion dollar business. Over the years, they’ve garnered a little action in the OTC market, but […]

by

By Dania Duran As more and more states across the US push towards marijuana reform, investors are increasingly seeing the plant and its chemical compounds as an emerging industry, ripe for the taking in what is fast becoming a multi-billion dollar business. Over the years, they’ve garnered a little action in the OTC market, but […]

by